Related Experiment Video
Updated: Aug 11, 2026

08:54
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Published on: May 20, 2020
[Primary and secondary chest wall tumors from the pathologist's viewpoint]
J Friemann1, A Roessner, K M Müller
1Institut für Pathologie der Berufsgenossenschaftlichen Krankenanstalten Bergmannsheil, Universitätsklinik, Bochum.
Summary
Fibrous dysplasia, metastases, and chondrosarcoma are common chest wall bone tumors. Rare soft tissue tumors also occur, requiring expert collaboration for accurate diagnosis.
Area of Science:
- Oncology
- Pathology
- Thoracic Surgery
Context:
- Chest wall tumors encompass both primary bone lesions and rare soft tissue neoplasms.
- Common bone tumors include fibrous dysplasia, metastases, and chondrosarcoma.
- Primary soft tissue tumors of the chest wall are infrequent, with exceptions like Askin tumor, Abrikosoff tumor, elastofibroma dorsi, and desmoid tumors.
Purpose:
- To review the common and rare tumors affecting the chest wall.
- To highlight the diagnostic challenges in classifying undifferentiated sarcomas and thoracic metastases.
- To emphasize the necessity of multidisciplinary collaboration for accurate histogenetic classification.
Summary:
- Fibrous dysplasia (20%), metastases (16%), and chondrosarcoma (11%) are the most frequent primary bone tumors of the chest wall.
- Primary soft tissue lesions of the chest wall are rare, with notable exceptions including Askin tumor, Abrikosoff tumor, elastofibroma dorsi, and desmoid tumors.
- Accurate histogenetic classification of undifferentiated sarcomas and thoracic metastases (e.g., prostatic carcinomas, mesotheliomas) necessitates close cooperation between surgeons and pathologists, supported by modern immunohistochemical investigations.
Impact:
- Provides a concise overview of chest wall tumor epidemiology.
- Underscores the importance of advanced diagnostic techniques and interdisciplinary communication in managing complex thoracic malignancies.
- Aids clinicians in recognizing and differentiating various chest wall tumor types, improving patient care and treatment strategies.

